Biomedical Ethics and Regulation
Biomedical Ethics and Regulation is a research topic within Physiology. Science Explorer counts 25k research works in it since 1950. 10.3% of them reached the world's top 10% most cited for their field and year.
This cluster of papers focuses on the regulation, ethical considerations, and challenges surrounding stem cell therapies and clinics. It covers topics such as patient safety, direct-to-consumer marketing, global governance, translational research, and the ethical implications of unproven therapies. The papers also discuss the need for comprehensive regulatory frameworks to ensure the safe and ethical development of regenerative medicine.
- Stem Cell Regulation
- Clinical Trials
- Regulatory Challenges
- Patient Safety
- Direct-to-Consumer Marketing
- Ethical Issues
- Global Governance
- Translational Research
- Unproven Therapies
- Regenerative Medicine
- Research works
- 25k fractional, since 1950
- In the world top 10%
- 2.6k per year above
- Top-10% rate
- 10.3% share of its works in the world top 10%
- Growth, 2018-21 → 2022-25
- +19% the tick is no change
- Largest producer
United States
47% of the 10 largest, 2022-now
This ranks research output and citation impact. It says nothing about the quality of diagnosis, treatment or care.
Which countries lead Biomedical Ethics and Regulation research?
By volume, the United States and the United Kingdom publish the most (1.9k and 452 works in 2022-now).
By volume, 2022-now
- 1
United States 1.9k works
- 2
United Kingdom 452 works
- 3
China 356 works
- 4
India 295 works
- 5
Germany 193 works
- 6
Canada 175 works
- 7
France 173 works
- 8
Japan 155 works
- 9
Italy 153 works
- 10
Australia 145 works
How concentrated that is
The same countries as shares of everything the list above accounts for. A node where two countries do two thirds of the work and one spread evenly across twelve read alike as a ranking and not at all alike here.
Shares of the rows listed above, not of the whole node.
Which institutions lead Biomedical Ethics and Regulation research?
By volume in 2022-now, Harvard University publishes the most Biomedical Ethics and Regulation research, followed by BMJ Group (United Kingdom) and University of North Carolina at Chapel Hill.
By volume, 2022-now
- 1
Harvard University
United States 83 works
- 2 BMJ Group (United Kingdom) 43 works
- 3
University of North Carolina at Chapel Hill
United States 41 works
- 4
Stanford University
United States 35 works
- 5
University College London
United Kingdom 33 works
- 6
University of Toronto
Canada 26 works
- 7
Centre National de la Recherche Scientifique
France 26 works
- 8
Johns Hopkins University
United States 25 works
- 9
King's College London
United Kingdom 24 works
- 10
Yale University
United States 24 works
Who are the leading researchers in Biomedical Ethics and Regulation?
The most-cited researchers publishing on Biomedical Ethics and Regulation include David Moher, Douglas G. Altman and Zulfiqar Ahmed Bhutta.
- 1
David Moher
Canada 898k citations
- 2
Douglas G. Altman
United Kingdom 862k citations
- 3
Zulfiqar Ahmed Bhutta
Pakistan 371k citations
- 4
Cyrus Cooper
United Kingdom 342k citations
- 5
Giuseppe Remuzzi
Italy 328k citations
- 6
John P. A. Ioannidis
United States 317k citations
- 7
Gordon Henry Guyatt
Canada 315k citations
- 8
Elie A. Akl
Canada 313k citations
- 9
Dan J. Stein
South Africa 306k citations
- 10
Róbert Langer
United States 303k citations
Ranked by citations received across their whole record, among researchers with at least three works on this topic.
Where is Biomedical Ethics and Regulation research done?
The largest centres of Biomedical Ethics and Regulation research in 2022-now are London (United Kingdom), New York (United States), Beijing (China) and Boston (United States). Among places with at least 20 works in it, it is an unusually large share of all research in London, Silver Spring and San Francisco.
Largest cities, 2022-now
- 1
London
United Kingdom 161 works
- 2
New York
United States 101 works
- 3
Beijing
China 84 works
- 4
Boston
United States 76 works
- 5
Washington D.C.
United States 67 works
- 6
Paris
France 66 works
- 7
Tokyo
Japan 61 works
- 8
Cambridge
United States 58 works
- 9
Houston
United States 45 works
- 10
Toronto
Canada 45 works
Where it is the local speciality
- London43.1 works52×
- Silver SpringUS · 23.2 works21×
- San FranciscoUS · 35.9 works5.2×
Location quotient: how much more of its research is in Biomedical Ethics and Regulation than the world average.
Where is the best place to study Biomedical Ethics and Regulation?
Among universities, judged by research, Harvard University, Utrecht University and Erasmus University Rotterdam score highest, combining excellence, specialisation, size, growth and international reach. Research strength is one signal when choosing where to study; it does not measure teaching.
One dot per university in the first ten of the table below, at the default weights. The upper left is the interesting corner: small places doing unusually strong work.
Universities only. The score blends excellence (40%), size (30%), specialisation (10%), growth (10%), international reach (10%), 2022-now; growth compares 2018-21 with 2022-25 and counts up to +20%, since a jump from a small base is mostly noise.
Every institution in Biomedical Ethics and Regulation, country by countryIs Biomedical Ethics and Regulation research growing?
Output in 2022-2025 was 19% higher than in 2018-2021, peaking in 2025. The fastest-growing topics are Biomedical Ethics and Regulation.
The same series as a ribbon: one cell per year, darker for more. The line above answers how much; this answers when.
Its share of all research
Growing output can still be a shrinking share: all of science grows. This is Biomedical Ethics and Regulation as a percentage of every work published that year, 0.024% in 2024.
Fractional works of Biomedical Ethics and Regulation over all fractional works that year. How the balance of science has shifted.
How much of it reaches the world top 10%
Year by year.
Of each year's works in it, the share that reached the world's 10% most cited for their field and year. A field is the world for its own topics, so there is no other line to hold it against.
Which topics inside it are moving
Growth and decline on one axis around a shared zero. Two lists side by side hide the thing that matters: whether the growth dwarfs the decline, or the other way round.
Discussion
Ask a question or share a note about Biomedical Ethics and Regulation. Posts are plain text and can be reported.